{"id":"co-trimoxazole-12","safety":{"commonSideEffects":[{"rate":"3-6","effect":"Rash"},{"rate":"3-8","effect":"Nausea"},{"rate":"1-4","effect":"Vomiting"},{"rate":"2-5","effect":"Diarrhea"},{"rate":"1-3","effect":"Hyperkalemia"},{"rate":"0.1-0.5","effect":"Stevens-Johnson syndrome"},{"rate":"0.5-1","effect":"Hepatotoxicity"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Sulfamethoxazole inhibits dihydropteroate synthase, while trimethoprim inhibits dihydrofolate reductase. Together, they block the bacterial synthesis of dihydrofolate and tetrahydrofolate, nucleotides essential for DNA synthesis. This synergistic dual inhibition provides broad-spectrum bactericidal activity against many gram-positive and gram-negative organisms.","oneSentence":"Co-trimoxazole is a fixed-dose combination of sulfamethoxazole and trimethoprim that inhibits bacterial folate synthesis at two sequential steps, preventing DNA replication.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:40:20.273Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial infections including urinary tract infections, respiratory tract infections, and otitis media"},{"name":"Pneumocystis jirovecii pneumonia (PCP) prophylaxis and treatment"},{"name":"Toxoplasmosis"}]},"trialDetails":[{"nctId":"NCT04466488","phase":"NA","title":"Prevent TB: Choice Architecture for TPT Delivery","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2021-09-15","conditions":"HIV/AIDS, Tuberculosis","enrollment":50798},{"nctId":"NCT05488340","phase":"PHASE2","title":"A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)","status":"RECRUITING","sponsor":"Locus Biosciences","startDate":"2022-07-13","conditions":"Urinary Tract Infections","enrollment":318},{"nctId":"NCT07485010","phase":"PHASE2","title":"Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Queensland","startDate":"2027-04","conditions":"Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection, Non-Tuberculous Mycobacterial (NTM) Infections","enrollment":300},{"nctId":"NCT05994742","phase":"PHASE3","title":"An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM","status":"ACTIVE_NOT_RECRUITING","sponsor":"Queen Mary University of London","startDate":"2024-07-15","conditions":"Severe Acute Malnutrition, HIV, Comorbidities and Coexisting Conditions","enrollment":674},{"nctId":"NCT01631617","phase":"PHASE2","title":"Effects of Treatments on Atopic Dermatitis","status":"RECRUITING","sponsor":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","startDate":"2012-09-18","conditions":"Eczema, Dermatitis, Skin Diseases, Genetic","enrollment":130},{"nctId":"NCT07451171","phase":"PHASE2","title":"Comparative Efficacy of Antibiotics for Small Intestine Bacterial Overgrowth in Bangladeshi Children","status":"NOT_YET_RECRUITING","sponsor":"University of Virginia","startDate":"2026-04","conditions":"Small Intestine Bacterial Overgrowth","enrollment":60},{"nctId":"NCT05398679","phase":"PHASE4","title":"Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis","status":"RECRUITING","sponsor":"Fundacion Clinic per a la Recerca Biomédica","startDate":"2022-08-17","conditions":"Endocarditis Infective","enrollment":360},{"nctId":"NCT07231770","phase":"NA","title":"Sulfamethoxazole Prophylaxis Duration After Renal Transplantation","status":"RECRUITING","sponsor":"Anhui Provincial Hospital","startDate":"2024-05-28","conditions":"Fever, Chest Tightness","enrollment":450},{"nctId":"NCT07106125","phase":"PHASE4","title":"Antibiotics for Kidney Transplant Recipients","status":"NOT_YET_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-11","conditions":"Kidney Transplant, Urinary Tract Infection(UTI), Antibiotic Prophylaxis","enrollment":50},{"nctId":"NCT03915366","phase":"PHASE2, PHASE3","title":"Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia","status":"COMPLETED","sponsor":"Hospital Universitario 12 de Octubre","startDate":"2020-03-01","conditions":"Pneumonia, HIV/AIDS, Tuberculosis","enrollment":563},{"nctId":"NCT04310930","phase":"PHASE2, PHASE3","title":"Finding the Optimal Regimen for Mycobacterium Abscessus Treatment","status":"RECRUITING","sponsor":"The University of Queensland","startDate":"2020-03-02","conditions":"Pulmonary Disease Due to Mycobacteria (Diagnosis)","enrollment":300},{"nctId":"NCT06676384","phase":"PHASE4","title":"Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?","status":"RECRUITING","sponsor":"Christian Medical College, Vellore, India","startDate":"2025-02-15","conditions":"IgA Nephropathy, Renal Insufficiency, Chronic, IgA Vasculitis","enrollment":585},{"nctId":"NCT06982105","phase":"PHASE4","title":"Trimethoprim-sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections","status":"RECRUITING","sponsor":"Indiana University","startDate":"2025-05-20","conditions":"Methicillin Resistant Staphylococcus Aureus, Osteomyelitis Acute, Septic Arthritis","enrollment":100},{"nctId":"NCT05925309","phase":"NA","title":"Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2023-07-01","conditions":"Biliary Atresia, Cholangitis, Anti-Bacterial Agents","enrollment":356},{"nctId":"NCT02164461","phase":"PHASE1","title":"Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer","status":"COMPLETED","sponsor":"Advaxis, Inc.","startDate":"2015-03-04","conditions":"Effects of Immunotherapy, Metastatic/Recurrent Cervical Cancer, Cervical Adenocarcinoma","enrollment":12},{"nctId":"NCT05678621","phase":"PHASE2, PHASE3","title":"Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension","status":"RECRUITING","sponsor":"Monash University","startDate":"2022-11-30","conditions":"Haematological Malignancy, Hypogammaglobulinemia","enrollment":300},{"nctId":"NCT05719285","phase":"PHASE4","title":"Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2022-12-06","conditions":"Overactive Bladder, Overactive Bladder Syndrome, Urge Incontinence","enrollment":100},{"nctId":"NCT05418777","phase":"PHASE1, PHASE2","title":"Treatment of Pneumocystis in COPD (the TOPIC Study)","status":"TERMINATED","sponsor":"Corewell Health East","startDate":"2022-09-28","conditions":"COPD Exacerbation Acute","enrollment":1},{"nctId":"NCT05199324","phase":"PHASE4","title":"Early Oral Step-down Antibiotic Therapy for Uncomplicated Gram-negative Bacteraemia","status":"UNKNOWN","sponsor":"Tan Tock Seng Hospital","startDate":"2022-04-01","conditions":"Gram-negative Bacteraemia","enrollment":720},{"nctId":"NCT03149237","phase":"NA","title":"Partners-based HIV Treatment for Couples Attending Antenatal Care","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2017-11-16","conditions":"Human Immunodeficiency Virus","enrollment":2160},{"nctId":"NCT00324922","phase":"PHASE3","title":"Vancomycin Or Trimethoprim/Sulfamethoxazole for Methicillin-resistant Staphylococcus Aureus Osteomyelitis","status":"COMPLETED","sponsor":"University of Washington","startDate":"2006-05-01","conditions":"Osteomyelitis, Methicillin-resistant Staphylococcus Aureus","enrollment":2},{"nctId":"NCT05575427","phase":"PHASE4","title":"Efficacy of Combination Therapy With Minocycline for Treatment of Stenotrophomonas Maltophilia Infections","status":"UNKNOWN","sponsor":"Mahidol University","startDate":"2022-11-24","conditions":"Hospital Infections","enrollment":112},{"nctId":"NCT02375295","phase":"PHASE4","title":"Struvite Stones Antibiotic Study","status":"UNKNOWN","sponsor":"University of British Columbia","startDate":"2015-03","conditions":"Kidney Stones","enrollment":28},{"nctId":"NCT03228108","phase":"PHASE4","title":"Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy.","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2018-04-03","conditions":"Complication, Infection, Prostate Cancer","enrollment":1538},{"nctId":"NCT02512198","phase":"NA","title":"Electronic Prescription Data to Improve Primary Care Prescribing","status":"COMPLETED","sponsor":"University of Dundee","startDate":"2015-07","conditions":"Physician's Practice Patterns","enrollment":236},{"nctId":"NCT04285320","phase":"PHASE4","title":"Antibiotic Bladder Instillations vs. Oral Suppression for the Treatment of Recurrent Urinary Tract Infections","status":"UNKNOWN","sponsor":"Atlantic Health System","startDate":"2021-03","conditions":"Recurrent Urinary Tract Infection","enrollment":100},{"nctId":"NCT02475876","phase":"PHASE1","title":"PK of Clindamycin and Trimethoprim-sulfamethoxazole in Infants and Children","status":"COMPLETED","sponsor":"Michael Cohen-Wolkowiez","startDate":"2015-11","conditions":"Bacterial Infections","enrollment":51},{"nctId":"NCT01420341","phase":"PHASE4","title":"Co-trimoxazole as Maintenance Therapy for Melioidosis","status":"COMPLETED","sponsor":"Khon Kaen University","startDate":"2011-08","conditions":"Melioidosis","enrollment":667},{"nctId":"NCT02795949","phase":"PHASE3","title":"Study on Reduced Antibiotic Treatment vs Broad Spectrum Betalactam in Patients With Bacteremia by Enterobacteriaceae","status":"COMPLETED","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2016-10","conditions":"Enterobacteriaceae Infections","enrollment":344},{"nctId":"NCT00691600","phase":"PHASE3","title":"Management of Skin and Soft Tissue Abscesses in Pediatric Patients After Incision and Drainage","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2007-12","conditions":"Abscess","enrollment":23},{"nctId":"NCT01229761","phase":"PHASE2","title":"Study to Improve Survival Among HIV-Exposed Infants in Botswana","status":"COMPLETED","sponsor":"Harvard School of Public Health (HSPH)","startDate":"2011-05","conditions":"HIV Infections, Neutropenia, Anemia","enrollment":3724},{"nctId":"NCT01659866","phase":"PHASE4","title":"Antibiotic Prophylaxis for Transrectal Prostate Biopsy","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2012-08","conditions":"Infection","enrollment":563},{"nctId":"NCT03535558","phase":"","title":"Fluoroquinolone Associated Disability","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2018-05-17","conditions":"Bronchitis, Sinusitis, Urinary Tract Infections","enrollment":239306},{"nctId":"NCT03395249","phase":"PHASE1","title":"Phase 1 Study of Safety, Tolerability and Pharmacokinetics of SPR994","status":"COMPLETED","sponsor":"Spero Therapeutics","startDate":"2017-10-20","conditions":"Healthy Volunteers","enrollment":124},{"nctId":"NCT01967758","phase":"PHASE1","title":"Phase I Study of Safety and Immunogenicity of ADU-623","status":"COMPLETED","sponsor":"Providence Health & Services","startDate":"2014-01-08","conditions":"Astrocytic Tumors, Glioblastoma Multiforme, Anaplastic Astrocytoma","enrollment":11},{"nctId":"NCT00078559","phase":"PHASE1, PHASE2","title":"Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2003-11","conditions":"Kidney Transplantation, Kidney Disease","enrollment":10},{"nctId":"NCT01349192","phase":"PHASE2","title":"Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2011-04","conditions":"Cystic Fibrosis, Methicillin-resistant Staphylococcus Aureus","enrollment":47},{"nctId":"NCT00141037","phase":"PHASE1, PHASE2","title":"Steroid-Free Versus Steroid-Based Immunosuppression in Pediatric Renal (Kidney) Transplantation","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2004-03","conditions":"Kidney Diseases, Kidney Transplantation, Kidney Transplant","enrollment":130},{"nctId":"NCT00023244","phase":"PHASE2","title":"Steroid Withdrawal in Pediatric Kidney Transplant Recipients","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2001-01","conditions":"End-Stage Renal Disease","enrollment":274},{"nctId":"NCT01449877","phase":"PHASE3","title":"Influence of Trimethoprim-Sulfamethoxazole for the Recurrence of Ocular Toxoplasmosis","status":"COMPLETED","sponsor":"University of Campinas, Brazil","startDate":"2011-10","conditions":"Ocular Toxoplasmosis","enrollment":141},{"nctId":"NCT01825031","phase":"PHASE3","title":"Reduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral Therapy","status":"COMPLETED","sponsor":"Anna Griffiths, MRC","startDate":"2013-06","conditions":"Human Immunodeficiency Virus","enrollment":1805},{"nctId":"NCT02473796","phase":"NA","title":"Home Based Child Care to Reduce Mortality and Malnutrition in Tribal Children of Melghat, India: CRCT","status":"COMPLETED","sponsor":"MAHAN Trust","startDate":"2004-01","conditions":"Acute Respiratory Tract Infections, Diarrhea, Malaria","enrollment":7594},{"nctId":"NCT01498744","phase":"NA","title":"Randomized Controlled Trial of Antibiotics in the Management of Children With Community-Acquired Abscess","status":"TERMINATED","sponsor":"Ann & Robert H Lurie Children's Hospital of Chicago","startDate":"2010-02","conditions":"Abscess Soft Tissue, Methicillin-resistant Staphylococcus Aureus (MRSA) Infection, Skin Abscess","enrollment":53},{"nctId":"NCT00002850","phase":"PHASE3","title":"Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy","status":"COMPLETED","sponsor":"Gary Morrow","startDate":"1997-03","conditions":"Infection, Multiple Myeloma","enrollment":212},{"nctId":"NCT00427076","phase":"PHASE3","title":"Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus Infections","status":"COMPLETED","sponsor":"Rabin Medical Center","startDate":"2007-06","conditions":"Staphylococcal Infections, Meningitis, Sepsis","enrollment":252},{"nctId":"NCT00522821","phase":"PHASE4","title":"Treatment of Deficient Subclass or Anti-polysaccharide Antibody Response","status":"COMPLETED","sponsor":"Prothya Biosolutions","startDate":"2007-11","conditions":"IgG Deficiency, Infections","enrollment":55},{"nctId":"NCT00109837","phase":"PHASE2","title":"S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"2005-04","conditions":"Leukemia","enrollment":79},{"nctId":"NCT01049633","phase":"","title":"B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure","status":"NO_LONGER_AVAILABLE","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"Type 1 Diabetes Mellitus","enrollment":""},{"nctId":"NCT02028676","phase":"PHASE4","title":"Efficacy Study of Different Laboratory Management Strategies and Drug Regimens in HIV-infected Children in Africa","status":"COMPLETED","sponsor":"Medical Research Council","startDate":"2007-03","conditions":"Human Immunodeficiency Virus","enrollment":1206},{"nctId":"NCT01757236","phase":"PHASE2","title":"Efficacy and Safety Study of Antibiotic Treatment to Treat Hip Prosthetic Joint Infection","status":"UNKNOWN","sponsor":"University Hospital, Tours","startDate":"2012-10","conditions":"Hip Prosthetic Joint Infection","enrollment":100},{"nctId":"NCT01808755","phase":"PHASE3","title":"D Mannose in Recurrent Urinary Tract Infections","status":"COMPLETED","sponsor":"Fondazione IRCCS Policlinico San Matteo di Pavia","startDate":"2012-01","conditions":"Recurrent Urinary Tract Infection","enrollment":60},{"nctId":"NCT02123628","phase":"PHASE4","title":"Antibiotic Treatment Duration for Non-Surgically-Treated Diabetic Foot Osteomyelitis","status":"COMPLETED","sponsor":"Tourcoing Hospital","startDate":"2007-06","conditions":"Diabetes Mellitus","enrollment":40},{"nctId":"NCT00940524","phase":"PHASE1","title":"Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2009-07","conditions":"Leukemia, Acute Lymphoblastic Leukemia","enrollment":7},{"nctId":"NCT00002571","phase":"PHASE2","title":"SWOG-9320 Combination Chemotherapy, Radiation Therapy, and Antiviral Therapy in Treating Patients With AIDS-Related Lymphoma","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"1994-06","conditions":"Lymphoma","enrollment":52},{"nctId":"NCT01747278","phase":"PHASE2, PHASE3","title":"Study of Trimethoprim/Sulfamethoxazole as PCP Prophylaxis in CTD Patients","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2012-08","conditions":"Pneumonia, Pneumocystis, Prevention & Control","enrollment":80},{"nctId":"NCT00720811","phase":"NA","title":"Assessment of Use of Rapid Diagnostic Testing in the Context of Home Management With ACTs","status":"COMPLETED","sponsor":"Mbarara University of Science and Technology","startDate":"2009-10","conditions":"Malaria, Pneumonia","enrollment":6456},{"nctId":"NCT01137903","phase":"NA","title":"Efficacy of Surgical Treatment of Osteomyelitis in Diabetic Foot Ulcers","status":"UNKNOWN","sponsor":"Universidad Complutense de Madrid","startDate":"2010-04","conditions":"Osteomyelitis, Diabetic Foot, Diabetic Foot Ulcers","enrollment":88}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1557,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Co-trimoxazole 12","genericName":"Co-trimoxazole 12","companyName":"Khon Kaen University","companyId":"khon-kaen-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Co-trimoxazole is a fixed-dose combination of sulfamethoxazole and trimethoprim that inhibits bacterial folate synthesis at two sequential steps, preventing DNA replication. Used for Bacterial infections including urinary tract infections, respiratory tract infections, and otitis media, Pneumocystis jirovecii pneumonia (PCP) prophylaxis and treatment, Toxoplasmosis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}